The first participant enrolled in the main RADAR-AD study has completed the two-month assessment period of the study. During this period the participant interacted with apps and wearable devices which measured their physical activity, sleep and heart rate, as well as thinking abilities and spatial navigation.
The goal of RADAR-AD is the development and validation of technology-enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease. To achieve this goal, the RADAD-AD consortium has set up three studies. The first and main one comprises the setting up of wearable devices at the time when participants visit the clinic. This study is executed across all participating European clinical sites.
The participant who finalised the first data collection period shares that they had a very positive experience. Among others, they said they liked the study, especially the app games. They enjoyed using the devices and, despite minor technical issues which were resolved very quickly, are happy to have participated in the study.
Marijn shares: “This positive experience is promising for the rest of the participants in the RADAR-AD study. I look forward to our next observations from other participants who will finalise their data collection period shortly.”